missing translation for 'onlineSavingsMsg'
Få mere at vide

Crenolanib, MedChemExpress

Artikelnummer. 16481727
Encompass_Preferred
Skift visning
Klik for at se tilgængelige muligheder
Mængde:
5 mg
10 mg
50 mg
100 mg
Pakningsstørrelse:
10mg
5mg
4 product options available for selection
Product selection table with 4 available options. Use arrow keys to navigate and Enter or Space to select.
Artikelnummer. Mængde unitSize
16481727 50 mg -
16418267 5 mg 5mg
16405568 10 mg 10mg
16466116 100 mg -
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 4 options available.
4 options
Denne vare kan ikke returneres. Se returpolicy
Artikelnummer. 16481727 Leverandør Medchem Express Leverandørnr. HY13223

Please to purchase this item. Need a web account? Register with us today!

Denne vare kan ikke returneres. Se returpolicy

MedChemExpress Crenolanib is a potent and selective inhibitor of wild-type and mutant isoforms of the class III receptor tyrosine kinases FLT3 and PDGFRα/β with Kds of 0.74 nM and 2.1 nM/3.2 nM, respectively.

Crenolanib is a potent and selective inhibitor of wild-type and mutant isoforms of the class III receptor tyrosine kinases FLT3 and PDGFRα/β with Kds of 0.74 nM and 2.1 nM/3.2 nM, respectively.

Specifications

Kemisk navn eller materiale Crenolanib
CAS 670220-88-9
Farve Off-White
Renhedsgrad noter Research
Molekylær formel C26H29N5O2
Mængde 50 mg
Synonym CP-868596
Opløselighedsinformation DMSO : 25 mg/mL (56.36 mM; ultrasonic and warming and heat to 60°C)
SMIL NC1CCN(C2=CC=CC3=C2N=C(N4C5=CC=C(C=C5N=C4)OCC6(COC6)C)C=C3)CC1
Molekylvægt (g/mol) 443.54
Formel vægt 443.54
Procent renhed 99.5%
Grad Research
Fysisk form Powder
Til brug med (applikation) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.